Mitochondrial protein phosphorylation as a regulatory modality: Implications for mitochondrial dysfunction in heart failure

35Citations
Citations of this article
58Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Phosphorylation of mitochondrial proteins has been recognized for decades, and the regulation of pyruvate- and branched-chain α-ketoacid dehydrogenases by an atypical kinase/phosphatase cascade is well established. More recently, the development of new mass spectrometry-based technologies has led to the discovery of many novel phosphorylation sites on a variety of mitochondrial targets. The evidence suggests that the major classes of kinase and several phosphatases may be present at the mitochondrial outer membrane, intermembrane space, inner membrane, and matrix, but many questions remain to be answered as to the location, timing, and reversibility of these phosphorylation events and whether they are functionally relevant. The authors review phosphorylation as a mitochondrial regulatory strategy and highlight its possible role in the pathophysiology of cardiac hypertrophy and failure. © 2011 Wiley Periodicals, Inc.

Cite

CITATION STYLE

APA

O’Rourke, B., van Eyk, J. E., & Foster, D. B. (2011, November). Mitochondrial protein phosphorylation as a regulatory modality: Implications for mitochondrial dysfunction in heart failure. Congestive Heart Failure. https://doi.org/10.1111/j.1751-7133.2011.00266.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free